Serum Level of Endogenous Secretory Receptor for Advanced Glycation End Products and Other Factors in Type 2 Diabetic Patients With Mild Cognitive Impairment

OBJECTIVE: Determine the serum levels of endogenous secretory receptor for advanced glycation end products (esRAGEs) in patients with type 2 diabetes and mild cognitive impairment (MCI) and in control patients with type 2 diabetes but no MCI, and examine the relationship of esRAGE and MCI with other...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Gang, Cai, Liangchun, Chen, Bin, Liang, Jixing, Lin, Fenhui, Li, Liantao, Lin, Lixiang, Yao, Jin, Wen, Junping, Huang, Huibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220856/
https://www.ncbi.nlm.nih.gov/pubmed/22011410
http://dx.doi.org/10.2337/dc11-0958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220856/
https://www.ncbi.nlm.nih.gov/pubmed/22011410
http://dx.doi.org/10.2337/dc11-0958

Ejemplares similares